INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 264 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $44,557,000 | -13.4% | 948,212 | -17.6% | 0.64% | -27.4% |
| Q1 2020 | $51,430,000 | +3.4% | 1,151,332 | +34.9% | 0.88% | +41.4% |
| Q4 2019 | $49,731,000 | -4.0% | 853,317 | -1.1% | 0.62% | -10.4% |
| Q3 2019 | $51,822,000 | +9.2% | 862,680 | +1.5% | 0.69% | +10.2% |
| Q2 2019 | $47,470,000 | -23.3% | 849,952 | -23.4% | 0.63% | -24.2% |
| Q1 2019 | $61,860,000 | +55.8% | 1,110,177 | +26.1% | 0.83% | +46.1% |
| Q4 2018 | $39,695,000 | +63.3% | 880,167 | +138.5% | 0.57% | +100.7% |
| Q3 2018 | $24,312,000 | +6.6% | 369,082 | +4.2% | 0.28% | +4.0% |
| Q2 2018 | $22,815,000 | -24.2% | 354,207 | -34.9% | 0.27% | -26.1% |
| Q1 2018 | $30,105,000 | +9.2% | 544,007 | -5.6% | 0.37% | +15.4% |
| Q4 2017 | $27,572,000 | -39.0% | 576,100 | -35.7% | 0.32% | -40.5% |
| Q3 2017 | $45,228,000 | -8.1% | 895,975 | -0.7% | 0.54% | -8.8% |
| Q2 2017 | $49,194,000 | +32.8% | 902,475 | +2.6% | 0.59% | +35.2% |
| Q1 2017 | $37,057,000 | +38.3% | 879,575 | +181.6% | 0.44% | +37.7% |
| Q4 2016 | $26,799,000 | +11.5% | 312,375 | +7.3% | 0.32% | +10.9% |
| Q3 2016 | $24,025,000 | -51.0% | 291,050 | -52.6% | 0.28% | -54.0% |
| Q2 2016 | $49,032,000 | +20.6% | 614,600 | +1.8% | 0.62% | +20.9% |
| Q1 2016 | $40,651,000 | -21.0% | 603,475 | -20.5% | 0.51% | -21.8% |
| Q4 2015 | $51,451,000 | -37.2% | 759,100 | -44.8% | 0.66% | -43.7% |
| Q3 2015 | $81,884,000 | +1.9% | 1,375,050 | +15.3% | 1.17% | +3.1% |
| Q2 2015 | $80,368,000 | +10.6% | 1,192,950 | +1.2% | 1.13% | +2.2% |
| Q1 2015 | $72,672,000 | -4.3% | 1,178,775 | -15.8% | 1.11% | +0.1% |
| Q4 2014 | $75,910,000 | +8.2% | 1,399,775 | -1.0% | 1.11% | +5.4% |
| Q3 2014 | $70,181,000 | +4.5% | 1,413,800 | -0.9% | 1.05% | +10.0% |
| Q2 2014 | $67,136,000 | +7.4% | 1,426,600 | +5.0% | 0.95% | +1.4% |
| Q1 2014 | $62,498,000 | -6.9% | 1,358,975 | -3.4% | 0.94% | -10.0% |
| Q4 2013 | $67,128,000 | +24.5% | 1,407,000 | +5.0% | 1.05% | +15.1% |
| Q3 2013 | $53,917,000 | +15.5% | 1,339,550 | +5.1% | 0.91% | +2.8% |
| Q2 2013 | $46,701,000 | – | 1,274,925 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |